Keyphrases
Inflammatory Bowel Disease
100%
Pediatric Autoimmune Diseases
87%
Autoimmune Disease
79%
Systemic Juvenile Idiopathic Arthritis (sJIA)
56%
Autoimmune Thyroiditis
54%
Type 1 Diabetes Mellitus (T1DM)
53%
School-age children
49%
Type I Diabetes
48%
Register-based
41%
Central Obesity
29%
Antibiotic Exposure
26%
Risk Factors
25%
Antibiotics
25%
Pre-diagnostic
23%
Perinatal Risk Factors
20%
Dietary Patterns
20%
Salivary Microbiome
20%
Proton Pump Inhibitors
20%
Pediatric Onset
20%
Enzyme Profile
20%
Biological Treatment
20%
Liver Enzymes
20%
Emotional Feeding
20%
Oral Vancomycin
20%
Vancomycin Therapy
20%
Real-world Observational Study
20%
Alanine Aminotransferase
19%
Preterm Birth
15%
Potential Risk Factors
12%
Gut Microbiota Composition
10%
Transaminase Elevations
10%
Preterm children
9%
Broad-spectrum Antibiotics
9%
Pediatric Type 1 Diabetes Mellitus
8%
Autoimmune
8%
Waist-to-height Ratio (WHtR)
8%
Residential Area
7%
Autoimmune Hepatitis
6%
Glutamyl Transpeptidase
6%
Overall Development
6%
Shared Risk Factors
6%
Primary Diagnosis
6%
Microbial Composition
5%
Age-specific
5%
Sex-specific
5%
Adjusted Odds Ratio
5%
Confidence Interval
5%
Infliximab
5%
Medicine and Dentistry
Inflammatory Bowel Disease
75%
Pediatrics
52%
Insulin Dependent Diabetes Mellitus
44%
Autoimmune Disease
34%
Autoimmune Thyroiditis
33%
Juvenile Idiopathic Arthritis
33%
School-Aged Child
25%
Diagnosis
20%
Alanine Aminotransferase
20%
Liver Enzyme
20%
Depressive Disorder
20%
Overnutrition
20%
Vancomycin
20%
Premature Labor
12%
Diabetes Mellitus
9%
Prematurity
9%
Odds Ratio
8%
Autoimmune Hepatitis
7%
Gamma-Glutamyl Transpeptidase
7%
Diseases
7%
Obesity
5%
Infliximab
5%
Pharmacology, Toxicology and Pharmaceutical Science
Autoimmune Disease
73%
Inflammatory Bowel Disease
66%
Juvenile Rheumatoid Arthritis
46%
Autoimmune Thyroiditis
46%
Insulin Dependent Diabetes Mellitus
30%
Antibiotics
23%
Proton Pump Inhibitor
20%
Liver Enzyme
20%
Alanine Aminotransferase
20%
Premature Labor
12%
Intestine Flora
10%
Diabetes Mellitus
9%
Prematurity
9%
Autoimmune Hepatitis
7%
Gamma Glutamyltransferase
7%
Diseases
7%
Infliximab
5%
